Home
Covid-19
Tools
Introduction to the Tools
Model Government Use Licences
Model Uses of Paragraph 7 or “LDC Waiver”
Special Compulsory Licences for Export of Medicines
Options for Regional Economic Communities
Voluntary Licences
TRIPS Flexibilities Database
Resources
Briefs & Briefing Documents
Publications
Tools
Useful Links
All Resources
Blog
About
Search
Medicines Law & Policy
Research and resources on intellectual property and health
Home
Covid-19
Tools
Introduction to the Tools
Model Government Use Licences
Model Uses of Paragraph 7 or “LDC Waiver”
Special Compulsory Licences for Export of Medicines
Options for Regional Economic Communities
Voluntary Licences
TRIPS Flexibilities Database
Resources
Briefs & Briefing Documents
Publications
Tools
Useful Links
All Resources
Blog
About
Tag: Medicines Pricing
Wrapping up 2019 – Noteworthy Medicines Law and Policy Events
Ellen 't Hoen
-
December 30, 2019
Socially Responsible Licensing of Medical Technologies
Ellen 't Hoen
-
December 9, 2019
Corbyn’s Compulsory Licenses. Will they work?
Ellen 't Hoen
-
September 26, 2019
Dutch Minister of Health writes open letter to pharma, threatens to...
Ellen 't Hoen
-
August 28, 2019
Drug Price Transparency Calls Move from South Africa to World Health...
Medicines Law & Policy
-
May 18, 2019
Humiragate: AbbVie’s desperate attempts to keep its monopoly
Ellen 't Hoen
-
March 27, 2019
Cancer Drug Pricing on the World Health Organization’s Executive Board Agenda
Ellen 't Hoen
-
January 23, 2019
Dutch health insurance company Menzis takes AstraZeneca to court over patent...
Ellen 't Hoen
-
September 20, 2018
New Dutch Foundation to Address High Medicines Pricing Announces Plan to...
Ellen 't Hoen
-
August 25, 2018
Pharmaceutical Pricing Hostages
Ellen 't Hoen
-
September 13, 2017
This work is licensed under Creative Commons.